Pick the best of both glucose and lipid metabolism
Isthmin‐1 is an adipokine that has a potent glucose‐lowering effect by stimulating a common intracellular signaling pathway with insulin through a distinct receptor and has an inhibitory effect on lipogenesis in the liver, whereas insulin has the opposite effect. Isthmin‐1 is expected to have clinic...
Saved in:
Published in | Journal of diabetes investigation Vol. 13; no. 7; pp. 1132 - 1133 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Japan
John Wiley & Sons, Inc
01.07.2022
John Wiley and Sons Inc Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Isthmin‐1 is an adipokine that has a potent glucose‐lowering effect by stimulating a common intracellular signaling pathway with insulin through a distinct receptor and has an inhibitory effect on lipogenesis in the liver, whereas insulin has the opposite effect. Isthmin‐1 is expected to have clinical benefits in the treatment of diabetes. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2040-1116 2040-1124 |
DOI: | 10.1111/jdi.13774 |